摘要
目的探讨瘤腔内注射凝血酶改良法在治疗医源性假性动脉瘤中的应用价值。方法回顾性分析2012年10月至2018年6月期间笔者所在医院28例介入诊疗术后出现的医源性假性动脉瘤患者的临床资料,其中21例采用超声引导下注射凝血酶治疗假性动脉瘤(简称超声组),7例采用DSA介导下用球囊封闭动脉瘤颈后注射凝血酶治疗假性动脉瘤(简称DSA组),并于术后1d、1个月和3个月随访复查。结果2组手术总成功率均为100%,2组无一例出现治疗相关并发症;治疗后1个月及3个月随访均无复发。结论瘤腔内注射凝血酶可用于医源性假性动脉瘤的治疗,改良治疗方式后效果更显著,此两种方法可作为治疗不同瘤颈口的医源性假性动脉瘤的选择方式。
Objective To explore the value of modified method for intratumoral injection of thrombin in the treatment of iatrogenic pseudoaneurysms. Methods Clinical data of 28 patients with iatrogenic pseudoaneurysms after interventional treatment in our hospital from October 2012 to June 2018 were retrospectively analyzed. Twenty-one cases were treated with ultrasound-guided thrombin injection for pseudoaneurysms (Ultrasound group), and seven cases were treated with DSA-mediated balloon occlusion and thrombin injection for pseudoaneurysms (DSA group). The patients were followed-up at 1 day, 1 month and 3 monthS after operation. Results The total success rates of the two groups were 100%. There was no treatment-related complications in the two groups. There was no recurrence after 1–3 months of treatment. Conclusions Intratumoral injection of thrombin can be used for the treatment of iatrogenic pseudoaneurysm. The effect of the improved treatment is more significant. These two methods can be used as the best way to treat iatrogenic pseudoaneurysm with different neck diameters.
作者
刘庆文
刘西平
郭赟
吴春苗
崔鹏
周鸿
刘莹
LIU Qingwen;LIU Xiping;GUO Yun;WU Chunmiao;CUI Peng;ZHOU Hong;LIU Ying(Department of Interventional Radiology,The Third People’s Hospital of Chengdu,The Affiliated Hospital of Southwest Jiaotong University,Chengdu 610031,P.R.China;Department of Ultrasound,The Third People’s Hospital of Chengdu,The Affiliated Hospital of Southwest Jiaotong University,Chengdu 610031,P.R.China)
出处
《中国普外基础与临床杂志》
CAS
2019年第10期1205-1208,共4页
Chinese Journal of Bases and Clinics In General Surgery
